297 related articles for article (PubMed ID: 18252963)
1. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
Buteau-Lozano H; Velasco G; Cristofari M; Balaguer P; Perrot-Applanat M
J Endocrinol; 2008 Feb; 196(2):399-412. PubMed ID: 18252963
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
5. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
6. Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.
Koduri S; Goldhar AS; Vonderhaar BK
Breast Cancer Res Treat; 2006 Jan; 95(1):37-43. PubMed ID: 16267616
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
Garvin S; Dabrosin C
Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
[TBL] [Abstract][Full Text] [Related]
8. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.
Chrzan BG; Bradford PG
Mol Nutr Food Res; 2007 Feb; 51(2):171-7. PubMed ID: 17266178
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
10. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
11. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogen receptor in the regulation of estrogen induced amino acid transport of System A in breast cancer and other receptor positive tumor cells.
Bhat HK; Vadgama JV
Int J Mol Med; 2002 Mar; 9(3):271-9. PubMed ID: 11836633
[TBL] [Abstract][Full Text] [Related]
13. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo.
Bergman Jungeström M; Thompson LU; Dabrosin C
Clin Cancer Res; 2007 Feb; 13(3):1061-7. PubMed ID: 17289903
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s).
Picard K; Lhuguenot JC; Lavier-Canivenc MC; Chagnon MC
Toxicol Appl Pharmacol; 2001 Apr; 172(2):108-18. PubMed ID: 11298497
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.
Seo HS; DeNardo DG; Jacquot Y; Laïos I; Vidal DS; Zambrana CR; Leclercq G; Brown PH
Breast Cancer Res Treat; 2006 Sep; 99(2):121-34. PubMed ID: 16541309
[TBL] [Abstract][Full Text] [Related]
16. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
Lee JE; Chung KW; Han W; Kim SW; Kim SW; Shin HJ; Bae JY; Noh DY
Anticancer Res; 2004; 24(6):3961-4. PubMed ID: 15736439
[TBL] [Abstract][Full Text] [Related]
17. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
18. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells.
Kim IY; Han SY; Moon A
J Toxicol Environ Health A; 2004 Dec; 67(23-24):2025-35. PubMed ID: 15513900
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
Coradini D; Pellizzaro C; Speranza A; Daidone MG
Cell Mol Life Sci; 2004 Jan; 61(1):76-82. PubMed ID: 14704855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
